Show simple item record

dc.contributor.authorWegner, Garret
dc.contributor.authorKhan, Amir
dc.contributor.authorPanagos, MIchael
dc.contributor.authorWang, Shu
dc.contributor.authorVan Besien, Alexa J.
dc.contributor.authorNaslund, Michael
dc.contributor.authorSiddiqui, M. Minhaj
dc.contributor.authorPanagos, Michael
dc.date.accessioned2024-05-17T17:22:06Z
dc.date.available2024-05-17T17:22:06Z
dc.date.issued2024-05-03
dc.identifier.urihttp://hdl.handle.net/10713/22106
dc.descriptionAmerican Urological Association Annual Conference. May 3, 2024.en_US
dc.description.abstractMultiparametric Magnetic Resonance Imaging (MP-MRI)/ ultrasound fusion guided biopsy (targeted biopsy) is emerging as an alternative diagnostic tool for Prostate cancer (PCa) in addition to historically used Transrectal Ultrasound-guided (TRUS) biopsy. Echogenicity observed during the fusion of MRI and ultrasound images may be associated with the detection of clinically significant prostate cancer in targeted biopsy of MP-MRI lesions.en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.lcshProstate--Canceren_US
dc.subject.meshMagnetic Resonance Imagingen_US
dc.subject.meshMultiparametric Magnetic Resonance Imagingen_US
dc.subject.meshUltrasonographyen_US
dc.titleEchogenicity Enhances Risk Assessment of Lesions on MP-MRI for Clinically Significant Prostate Canceren_US
dc.typePoster/Presentationen_US
refterms.dateFOA2024-05-17T17:22:07Z


Files in this item

Thumbnail
Name:
Wegner_Echogenicity-enhances_2 ...
Size:
455.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International